News

Study reveals how SOX9 may unlock gastric cancer development

A new study from EBC core faculty member Eunyoung Choi, PhD, was published July 14 in the journal Gastroenterology.

Read More

Motor protein plays key role in intestinal stem cell identity, function

Izumi Kaji, PhD, assistant professor of Surgery, and colleagues are studying the function of MYO5B in the intestine, with the goal of identifying alternative, less invasive treatment options for…

Read More

Study challenges traditional assumptions about gut inflammation and Crohn’s disease

Professor of Cell and Developmental Biology and EBC core faculty member Ken Lau, PhD, and his lab published new research that challenges a longstanding assumption about Crohn’s disease: that all…

Read More

SPORE grant funds $12 million for colorectal cancer research

A colorectal cancer research team led by EBC co-director Robert Coffey, MD, has received a prestigious Specialized Programs of Research Excellence (SPORE) grant renewal totaling $12.6 million from…

Read More

Drug shows safety, efficacy for precancerous stomach lesions

Results of an early-stage clinical trial were pleasantly surprising, said EBC co-director and study collaborator James Goldenring, MD, PhD, professor of Surgery and of Cell and Developmental…

Read More